Center For International Blood And Marrow Transplant Research

This study tests a stem cell transplant using donors who are not a perfect match for patients with blood cancers like leukemia and lymphoma. Doctors give special drugs after the transplant to lower the risk of graft-versus-host disease, a common complication. The goal is to see i…

This study tests whether lower doses of chemotherapy (busulfan) before a stem cell transplant can help babies with severe combined immunodeficiency (SCID) build a strong immune system with fewer side effects. About 56 infants receiving stem cells from unrelated or half-matched do…

This study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant from a partially matched donor, can reduce serious infections in the first 100 days while still preventing graft-versus-host disease. About 313 adults with various blood cancers…

This study looks at whether a sensitive blood test can predict if acute myeloid leukemia (AML) will come back after a stem cell transplant. Researchers will follow 303 adults with AML in remission who are getting a transplant. The goal is to see if the test can help doctors catch…